Zhang B, Lang Z, Zhu K, Luo W, Zhao Z, Zhang Z
BMC Gastroenterol. 2025; 25(1):161.
PMID: 40069629
PMC: 11900024.
DOI: 10.1186/s12876-025-03761-x.
Jarvis M, Laing R, James A
BJA Educ. 2025; 25(2):57-64.
PMID: 39897427
PMC: 11785549.
DOI: 10.1016/j.bjae.2024.10.001.
Claridge H, Price C, Ali R, Cooke E, de Lusignan S, Harvey-Sullivan A
BMJ Open. 2024; 14(1):e079863.
PMID: 38262635
PMC: 10806670.
DOI: 10.1136/bmjopen-2023-079863.
Ahuja M, Pande R, Chugtai S, Brown R, Cain O, Bartlett D
Diagnostics (Basel). 2023; 13(22).
PMID: 37998601
PMC: 10670022.
DOI: 10.3390/diagnostics13223465.
Lu B, Chen Y, Qin S, Chen J
Saudi J Gastroenterol. 2023; 30(3):154-161.
PMID: 37988064
PMC: 11198917.
DOI: 10.4103/sjg.sjg_296_23.
Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pancreatoduodenectomy Patients.
Halle-Smith J, Powell-Brett S, Hall L, Duggan S, Griffin O, Phillips M
Cancers (Basel). 2023; 15(9).
PMID: 37173931
PMC: 10177139.
DOI: 10.3390/cancers15092466.
Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC.
Jacobsen A, Hobbs M, Merkel S, Mittelstadt A, Czubayko F, Krautz C
J Clin Med. 2022; 11(15).
PMID: 35956049
PMC: 9369379.
DOI: 10.3390/jcm11154433.
Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma.
Pande R, Chughtai S, Ahuja M, Brown R, Bartlett D, Dasari B
World J Gastrointest Surg. 2022; 14(5):429-441.
PMID: 35734625
PMC: 9160687.
DOI: 10.4240/wjgs.v14.i5.429.
DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and C-mixed triglyceride breath test as screening tools in high-risk individuals.
Afolabi P, McDonnell D, Byrne C, Wilding S, Goss V, Walters J
BMJ Open. 2022; 12(2):e057271.
PMID: 35217541
PMC: 8883257.
DOI: 10.1136/bmjopen-2021-057271.
Pattern of Time-to-Surgery in Patients With Breast Cancer at Different Stages of the COVID-19 Pandemic.
Chen R, Yang J, Zhao X, Fu Z, Wang Z, Qiu C
Front Oncol. 2022; 11:820638.
PMID: 35096625
PMC: 8790243.
DOI: 10.3389/fonc.2021.820638.
'Fast-track' pathway for resectable pancreatic cancer: barriers and facilitators to implementation across a regional network.
Yannoulias B, Exworthy M, Roberts K
Future Healthc J. 2021; 8(3):e717-e721.
PMID: 34888474
PMC: 8651305.
DOI: 10.7861/fhj.2021-0042.
Association of the rate of bilirubin decrease with major morbidity in patients undergoing preoperative biliary drainage before pancreaticoduodenectomy.
Rungsakulkij N, Thongchai V, Suragul W, Vassanasiri W, Tangtawee P, Muangkaew P
SAGE Open Med. 2021; 9:20503121211039667.
PMID: 34422273
PMC: 8375332.
DOI: 10.1177/20503121211039667.
An analysis of the incidence, causes and preventative approaches to gram-negative bloodstream infections of hepatopancreatobiliary origin.
Majeed M, Ward H, Wade C, Butcher L, Soonawalla Z, Bond-Smith G
J Infect Prev. 2021; 22(3):111-118.
PMID: 34239609
PMC: 8113670.
DOI: 10.1177/1757177420973763.
Survival Advantage of Upfront Surgery for Pancreatic Head Cancer Without Preoperative Biliary Drainage.
Pande R, Hodson J, Marudanayagam R, Chatzizacharias N, Dasari B, Muiesan P
Front Oncol. 2020; 10:526514.
PMID: 33251128
PMC: 7673268.
DOI: 10.3389/fonc.2020.526514.
Coronavirus Disease 2019 Pandemic: Potential Collateral Damage on Patients With Operable Pancreatic Cancer.
Pericleous S, Bhogal R
Pancreas. 2020; 49(7):e61-e62.
PMID: 32604204
PMC: 7375180.
DOI: 10.1097/MPA.0000000000001594.
Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer-Where Is the Least Harm and Most Benefit?.
Pande R, Roberts K
Front Oncol. 2019; 9:1060.
PMID: 31681596
PMC: 6811510.
DOI: 10.3389/fonc.2019.01060.
Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer.
Pande R, Hodson J, Murray A, Marcon F, Kalisvaart M, Marudanayagam R
BJS Open. 2019; 3(4):476-484.
PMID: 31388640
PMC: 6677092.
DOI: 10.1002/bjs5.50161.
Receipt of Curative Resection or Palliative Care for Hepatopancreaticobiliary Tumours (RICOCHET): Protocol for a Nationwide Collaborative Observational Study.
JMIR Res Protoc. 2019; 8(7):e13566.
PMID: 31287068
PMC: 6643763.
DOI: 10.2196/13566.
Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma.
Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F
Langenbecks Arch Surg. 2019; 404(4):439-449.
PMID: 30972486
PMC: 6614162.
DOI: 10.1007/s00423-019-01779-w.
Development and multicentre validation of a prognostic model to predict resectability of pancreatic head malignancy.
Gerken K, Roberts K, Reichert B, Sutcliffe R, Marcon F, Kamarajah S
BJS Open. 2018; 2(5):319-327.
PMID: 30263983
PMC: 6156170.
DOI: 10.1002/bjs5.79.